DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
申请人:Theravance, Inc.
公开号:EP1723142A1
公开(公告)日:2006-11-22
US7250414B2
申请人:——
公开号:US7250414B2
公开(公告)日:2007-07-31
US7557126B2
申请人:——
公开号:US7557126B2
公开(公告)日:2009-07-07
[EN] DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS<br/>[FR] COMPOSES DE DIPHENYLMETHYLE, ANTAGONISTES DU RECEPTEUR MUSCARINIQUE
申请人:THERAVANCE INC
公开号:WO2005087763A1
公开(公告)日:2005-09-22
This invention provides compounds of formula I wherein a, b, c, e, m, n, Ar1, R1, R2, R3, R4a, R4b, R5 and R6 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
Diphenylmethyl compounds useful as muscarinic receptor antagonists
申请人:Mammen Mathai
公开号:US20050203167A1
公开(公告)日:2005-09-15
This invention provides compounds of formula I:
wherein a, b, c, e, m, n, Ar
1
, R
1
, R
2
, R
3
, R
4a
, R
4b
, R
5
and R
6
are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.